In most of the invasive human breast cancers such as ER+ luminal A and luminal B, CLDN-1 expression is found to be downregulated, while an increased expression and cytoplasmic delocalization of CLDN-1 has been observed in some of the aggressive ER- basal-like breast cancer (BLBC) subtypes [40,72,73]. This evidence concerns the gene ESR1 and breast carcinoma.